In this issue:
Causal association between psoriasis and psychological illnesses
Risk of breast cancer among patients with psoriasis
Drug survival of biologics and non-biologics in palmoplantar psoriasis
Increased dental comorbidities in patients with psoriasis
Predictive factors of atopic-like dermatitis induced by IL-17A inhibitors
Factors in progression from psoriasis vulgaris to generalised pustular psoriasis
Psoriasis disease severity, special area involvement and patient-reported outcomes
Response to IL-17A inhibitors according to prior biologic exposures
Efficacy and safety of tildrakizumab in older patients
Predictors of effectiveness of risankizumab for psoriasis
Please login below to download this issue (PDF)